A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis

Published:2021-08 Issue:8 Volume:18 Page:1291-1297
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Blackwell Timothy S.¹²³,Hewlett Justin C.¹,Mason Wendi R.¹,Martin Susan¹,Del Greco James¹,Ding Guixiao¹,Wu Pingsheng¹⁴,Lancaster Lisa H.¹,Loyd James E.¹,Dudenhofer Rosemarie B.¹,Salisbury Margaret L.¹^ORCID,Kropski Jonathan A.¹²³

Affiliation:

1. Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine and

2. Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee; and

3. Department of Veterans Affairs Medical Center, Nashville, Tennessee

4. Department of Biostatistics, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Reference27 articles.

1. Idiopathic Pulmonary Fibrosis

2. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

3. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

4. Viral infection and aging as cofactors for the development of pulmonary fibrosis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis;Pharmaceutical Science Advances;2024-12

3. Valaciclovir for Epstein-Barr Virus Suppression in Moderate-to-Severe COPD;CHEST;2023-09

4. Trials and Treatments: An Update on Pharmacotherapy for Idiopathic Pulmonary Fibrosis;Life;2023-02-10

5. Targeting Human Herpesviruses: An Effective Strategy for Treating Idiopathic Pulmonary Fibrosis?;Annals of the American Thoracic Society;2021-08